Skip to content
Clinical Trials – home
NorwayBack to Norway

Clinical trials in Fredrikstad – page 7

89 clinical trials in Fredrikstad, Norway. Every trial is listed in the EU Clinical Trials Register and updated daily.

NorwayOur site in NorwayKliniske-Studier.no(opens in a new tab)
Fredrikstad at a glance
89
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

89 trials in Fredrikstad

Open in trial search

Plasma cell myeloma

Not recruiting

Study on Early Treatment for Multiple Myeloma Relapse Using Carfilzomib, Bortezomib, Daratumumab, Lenalidomide, and Dexamethasone in Patients with MRD Negativity

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Bortezomib
  • Sponsor:Oslo University Hospital HF

Study comparing tenecteplase and acetylsalicylic acid in patients with central retinal artery occlusion within 4.

Registered drug
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Oslo University Hospital HF

Study on the Safety and Effectiveness of Rilzabrutinib for Adults and Adolescents with Persistent or Chronic Immune Thrombocytopenia (ITP)

Investigational
Countries:NorwayNorway
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Rilzabrutinib
  • Sponsor:Principia Biopharma Inc.

Study on Povetacicept for Patients with Autoimmune Cytopenias (wAIHA, CAD, ITP)

InvestigationalNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Povetacicept
  • Sponsor:Alpine Immune Sciences Inc.

Rheumatoid arthritis

Not recruiting

Study on Monitoring Adalimumab for Maintaining Disease Control in Adults with Rheumatoid Arthritis

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years
  • Substances:Adalimumab
  • Sponsor:Diakonhjemmet Sykehus AS

Atrial fibrillation+2

Not recruiting

Study on Asundexian and Apixaban for Preventing Stroke in Adults with Atrial Fibrillation at Risk for Stroke

Registered drug
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Apixaban
  • Sponsor:Bayer AG

Study on the Effect of Adding Thoracic Radiotherapy to Durvalumab and Chemotherapy for Patients with Extensive Stage Small-Cell Lung Cancer

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Durvalumab
  • Sponsor:Norwegian University Of Science And Technolology

Lung disorder

Not recruiting

Study on Baricitinib for Hospitalized Patients with Severe or Critical COVID-19

Registered drug
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Baricitinib
  • Sponsor:Oslo University Hospital HF

Lung disorder

Not recruiting

Study on the Effectiveness and Safety of Bemcentinib for Hospitalized Patients with Moderate COVID-19

Investigational
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Bemcentinib
  • Sponsor:Oslo University Hospital HF

Monkeypox

Not recruiting

Study on Monkeypox Virus Disease: Effects of Tecovirimat in Patients with and without Antiviral Treatment

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Tecovirimat
  • Sponsor:University Of Oxford

Study on the Safety and Effects of AZD4831 for Adults with Non-Cirrhotic Non-Alcoholic Steatohepatitis (NASH) with Fibrosis

Investigational
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:AZD4831
  • Sponsor:AstraZeneca AB

COVID-19

Not recruiting

Study on Antiviral Therapy with Nirmatrelvir and Remdesivir for Immunocompromised COVID-19 Patients

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Nirmatrelvir
  • Sponsor:Institut National De La Sante Et De La Recherche Medicale

Other cities in Norway

The busiest research cities in the country

All 53 cities in Norway

Clinical research in Fredrikstad

What the registry says about research in the country

01 Oncology Research

Innovative studies focusing on precision cancer medicine for rare and hard-to-treat cancers, including groundbreaking research in metastatic prostate cancer and melanoma treatment approaches.

  • Advanced Cancer Therapies
  • Targeted Drug Development
  • Biomarker-Driven Treatment

Research emphasizes personalized treatment strategies and novel drug applications.

02 Hematology Studies

Comprehensive research on Immune Thrombocytopenia (ITP) and related blood disorders, evaluating new therapeutic approaches and drug efficacy.

  • Blood Disorder Treatments
  • Thrombosis Management
  • Innovative Drug Therapies

Focus on developing effective treatments for various blood-related conditions.

03 Neurological & Mental Health

Studies examining treatment outcomes in schizophrenia patients, with particular attention to cognitive impairment and long-term safety assessments.

  • Cognitive Function
  • Mental Health Therapeutics
  • Safety Evaluations

Emphasis on improving patient outcomes through targeted interventions.

04 Musculoskeletal Conditions

Research investigating treatments for rheumatoid arthritis and chronic low back pain, including innovative therapeutic monitoring approaches.

  • Pain Management
  • Inflammatory Conditions
  • Drug Monitoring Studies

Focus on improving quality of life through effective disease management.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.